Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 3 (2007), Issue 12 (December)

1. Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.
   J Pain Symptom Manage, 34(6): 628-38. [Abstract] [Full-text]
2. Complementary and alternative therapies in pediatric oncology.
   Pediatr Clin North Am, 54(6): 1043-60. [Abstract] [Full-text]
3. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology.
   Lancet Oncol, 8(12): 1101-15. [Abstract] [Full-text]
4. Developing a multidisciplinary geriatric oncology program in a community cancer center.
   Clin J Oncol Nurs, 11(6): 929-33. [Abstract] [Full-text]
5. Oncology-critical care nursing collaboration: recommendations for optimizing continuity of care of critically ill patients with cancer.
   Clin J Oncol Nurs, 11(6): 925-7. [Abstract] [Full-text]
6. Multiple myeloma and treatment-related thromboembolism: oncology nurses' role in prevention, assessment, and diagnosis.
   Clin J Oncol Nurs, 11(6): 847-51. [Abstract] [Full-text]
7. Does the number of exogenous infections increase in paediatric oncology patients when sterile surgical gloves are not worn for accessing Central Venous Access Devices?
   Eur J Oncol Nurs, 11(5): 442-7. [Abstract] [Full-text]
8. Optimal and minimax three-stage designs for phase II oncology clinical trials.
   Contemp Clin Trials, 29(1): 32-41. [Abstract] [Full-text]
9. Palliative care in orthopaedic surgical oncology.
   Surg Oncol, 16(4): 311-30. [Abstract] [Full-text]
10. Needs of developing the skills of palliative care at the oncology ward: an audit of symptoms among 203 consecutive cancer patients in Finland.
    Support Care Cancer, 16(1): 3-8. [Abstract] [Full-text]
11. Cell cycle markers in clinical oncology.
    Curr Opin Cell Biol, 19(6): 672-679. [Abstract] [Full-text]
12. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.
    Pediatr Blood Cancer, 50(2): 254-8. [Abstract] [Full-text]
13. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
    Pediatr Blood Cancer, 50(2): 227-30. [Abstract] [Full-text]
14. Nutritional status of children during treatment for acute lymphoblastic leukemia in the Central American Pediatric Hematology Oncology Association (AHOPCA): preliminary data from Guatemala.
    Pediatr Blood Cancer, 50(2): 502-5; discussion 517. [Abstract] [Full-text]
15. Children's Oncology Group (COG) Nutrition Committee.
    Pediatr Blood Cancer, 50(2): 447-50; discussion 451. [Abstract] [Full-text]
16. The Will Rogers phenomenon in urological oncology.
    J Urol, 179(1): 28-33. [Abstract] [Full-text]
17. The need to develop centers for environmental oncology.
    Biomed Pharmacother, 61(10): 614-22. [Abstract] [Full-text]
18. An outline of the history of head and neck oncology.
    Oral Oncol, 44(1): 2-9. [Abstract] [Full-text]
19. Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208.
    Cancer Sci, 99(1): 145-51. [Abstract] [Full-text]
20. Predictive and prognostic markers in neuro-oncology.
    J Neuropathol Exp Neurol, 66(12): 1074-81. [Abstract] [Full-text]
21. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
    J Clin Oncol, 25(36): 5800-7. [Abstract] [Full-text]
22. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.
    Blood, 111(1): 25-41. [Abstract] [Full-text]
23. Computerised assessment of quality of life in oncology patients and carers.
    Psychooncology, 17(1): 26-33. [Abstract] [Full-text]
24. Two cycles of etoposide/cisplatin cured all patients with stage I testicular seminoma: risk-adapted protocol of the Hellenic Cooperative Oncology Group.
    Urology, 70(6): 1179-83. [Abstract] [Full-text]
25. Management of venous port systems in oncology: a review of current evidence.
    Ann Oncol, 19(1): 9-15. [Abstract] [Full-text]
26. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.
    J Clin Oncol, 26(1): 132-49. [Abstract] [Full-text]
27. Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200).
    Gynecol Oncol, 108(1): 90-4. [Abstract] [Full-text]
28. An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Gynecol Oncol, 108(1): 3-9. [Abstract] [Full-text]
29. Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
    Ann Oncol, 19(1): 115-22. [Abstract] [Full-text]
30. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
    Gynecol Oncol, 108(1): 226-33. [Abstract] [Full-text]
31. Oncology nurses' use of nondrug pain interventions in practice.
    J Pain Symptom Manage, 35(1): 83-94. [Abstract] [Full-text]
32. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    J Clin Oncol, 26(1): 83-9. [Abstract] [Full-text]
33. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
    J Clin Oncol, 26(1): 112-20. [Abstract] [Full-text]
34. Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.
    J Clin Oncol, 26(1): 60-5. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.